Takenao Odagami,Hiroyuki Kouji,Yoichi Ozawa,Yusaku Hori
申请号：
US15736561
公开号：
US20180185395A1
申请日:
2016.06.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention aims to provide a therapeutic drug for cancer having a superior treatment effect. A cancer treatment using a CBP/catenin inhibitor and an immune checkpoint inhibitor in combination not only increases a treatment effect on cancer, but also enables an effective treatment of cancer patients showing low sensitivity when an immune checkpoint inhibitor is used alone.
